This week, valbenazine became the first-ever drug approved by the Food and Drug Administration (FDA) for the treatment of tardive dyskinesia. Today, Psych Unseen answers some questions about the ...
The study – the largest double-blind placebo-controlled clinical trial ever completed in DCP – evaluated the efficacy of 14 weeks of treatment with valbenazine compared with placebo in pediatric and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results